Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1987 3
1988 2
1989 2
1990 2
1991 4
1992 1
1995 3
1996 2
1997 3
1998 5
1999 1
2000 1
2001 3
2002 1
2003 1
2004 4
2006 2
2007 2
2008 2
2009 2
2010 5
2011 5
2013 2
2014 2
2015 3
2016 5
2017 1
2018 2
2019 1
2020 2
2021 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Results by year
Filters applied: . Clear all
Page 1
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.
Quénet F, Elias D, Roca L, Goéré D, Ghouti L, Pocard M, Facy O, Arvieux C, Lorimier G, Pezet D, Marchal F, Loi V, Meeus P, Juzyna B, de Forges H, Paineau J, Glehen O; UNICANCER-GI Group and BIG Renape Group. Quénet F, et al. Among authors: lorimier g. Lancet Oncol. 2021 Feb;22(2):256-266. doi: 10.1016/S1470-2045(20)30599-4. Epub 2021 Jan 18. Lancet Oncol. 2021. PMID: 33476595 Clinical Trial.
Lorimier G, Talha A, Guntz M. Lorimier G, et al. J Chir (Paris). 1989 Feb;126(2):103-13. J Chir (Paris). 1989. PMID: 2715223 French.
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.
Goéré D, Glehen O, Quenet F, Guilloit JM, Bereder JM, Lorimier G, Thibaudeau E, Ghouti L, Pinto A, Tuech JJ, Kianmanesh R, Carretier M, Marchal F, Arvieux C, Brigand C, Meeus P, Rat P, Durand-Fontanier S, Mariani P, Lakkis Z, Loi V, Pirro N, Sabbagh C, Texier M, Elias D; BIG-RENAPE group. Goéré D, et al. Among authors: lorimier g. Lancet Oncol. 2020 Sep;21(9):1147-1154. doi: 10.1016/S1470-2045(20)30322-3. Epub 2020 Jul 24. Lancet Oncol. 2020. PMID: 32717180 Clinical Trial.
[Retroperitoneal lymphadenectomy and survival of patients treated for an advanced ovarian cancer: the CARACO trial].
Classe JM, Cerato E, Boursier C, Dauplat J, Pomel C, Villet R, Cuisenier J, Lorimier G, Rodier JF, Mathevet P, Houvenaeghel G, Leveque J, Lécuru F. Classe JM, et al. Among authors: lorimier g. J Gynecol Obstet Biol Reprod (Paris). 2011 May;40(3):201-4. doi: 10.1016/j.jgyn.2011.02.009. Epub 2011 Apr 8. J Gynecol Obstet Biol Reprod (Paris). 2011. PMID: 21482037 Free article. Review. French.
[Contusions of the liver].
Lorimier G, Guntz M. Lorimier G, et al. J Chir (Paris). 1988 Feb;125(2):114-20. J Chir (Paris). 1988. PMID: 3284892 Review. French. No abstract available.
Intra-abdominal recurrence from colorectal carcinoma: Differences and similarities between local and peritoneal recurrence.
Dumont F, Joseph S, Lorimier G, De Franco V, Wernert R, Verriele V, Kerdraon O, Campion L, Capitain O, Guerin-Meyer V, Raimbourg J, Senellart H, Hiret S, Raoul JL, Thibaudeau E. Dumont F, et al. Among authors: lorimier g. Surg Oncol. 2020 Mar;32:23-29. doi: 10.1016/j.suronc.2019.10.018. Epub 2019 Nov 4. Surg Oncol. 2020. PMID: 31707314
72 results